As of the latest Form 4 filed Jul 8, 2026.
What Relay Therapeutics Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 29 most recent filings for RLAY.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-08 | 2026-07-07 | Patel Sanjiv President and CEO | SSale | −48.2K | $19.58 | $944K | Yes (planned) | Form 4 ↗ |
| 2026-07-08 | 2026-07-06 | Bergstrom Donald A President, R&D | SSale | −8.66K | $18.71 | $162K | Yes (planned) | Form 4 ↗ |
| 2026-07-08 | 2026-07-06 | Catinazzo Thomas Chief Financial Officer | SSale | −17.7K | $18.69 | $331K | Yes (planned) | Form 4 ↗ |
| 2026-07-08 | 2026-06-30 | Patel Sanjiv President and CEO | AAward | +3.06K | $6.95 | $21.2K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Rahmer Peter See remarks | AAward | +3.06K | $6.95 | $21.2K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Rahmer Peter, See remarks | SSale | −50.0K | $19.09 | $955K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Catinazzo Thomas Chief Financial Officer | SSale | −51.6K | $16.97 | $875K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Catinazzo Thomas, Chief Financial Officer | MExercise | +51.6K | $4.45 | $229K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Catinazzo Thomas, Chief Financial Officer | SSale | −61.6K | $16.97 | $1.04M | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Catinazzo Thomas, Chief Financial Officer | MExercise | +61.6K | $5.22 | $321K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Catinazzo Thomas, Chief Financial Officer | SSale | −56.3K | $16.97 | $956K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Catinazzo Thomas, Chief Financial Officer | MExercise | +56.3K | $5.04 | $284K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Catinazzo Thomas, Chief Financial Officer | SSale | −17.7K | $17.01 | $301K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Bergstrom Donald A President, R&D | SSale | −93.5K | $16.94 | $1.58M | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Bergstrom Donald A, President, R&D | MExercise | +93.5K | $4.12 | $385K | Yes (planned) | Form 4 ↗ |
| 2026-05-14 | 2026-05-14 | Catinazzo Thomas Chief Financial Officer | SSale | −17.7K | $12.86 | $228K | Yes (planned) | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | Catinazzo Thomas Chief Financial Officer | SSale | −972.00 | $14.79 | $14.4K | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | Rahmer Peter See remarks | SSale | −753.00 | $14.79 | $11.1K | No | Form 4 ↗ |
| 2026-04-30 | 2026-04-28 | Bergstrom Donald A President, R&D | SSale | −1.49K | $14.79 | $22.0K | No | Form 4 ↗ |
| 2026-04-09 | 2026-04-09 | Catinazzo Thomas Chief Financial Officer | SSale | −1.80K | $15.00 | $27.0K | Yes (planned) | Form 4 ↗ |
| 2026-04-09 | 2026-04-09 | Catinazzo Thomas, Chief Financial Officer | MExercise | +1.80K | $5.22 | $9.40K | Yes (planned) | Form 4 ↗ |
| 2026-04-09 | 2026-04-07 | Catinazzo Thomas, Chief Financial Officer | SSale | −17.7K | $13.01 | $230K | Yes (planned) | Form 4 ↗ |
| 2026-01-29 | 2026-01-28 | Bergstrom Donald A President, R&D | SSale | −2.69K | $8.45 | $22.7K | No | Form 4 ↗ |
| 2026-01-29 | 2026-01-28 | Rahmer Peter See remarks | SSale | −1.35K | $8.45 | $11.4K | No | Form 4 ↗ |
| 2026-01-29 | 2026-01-28 | Catinazzo Thomas Chief Financial Officer | SSale | −1.70K | $8.45 | $14.3K | No | Form 4 ↗ |
| 2026-01-29 | 2026-01-27 | Bergstrom Donald A President, R&D | SSale | −18.9K | $7.62 | $144K | No | Form 4 ↗ |
| 2026-01-29 | 2026-01-27 | Rahmer Peter See remarks | SSale | −11.7K | $7.62 | $89.0K | No | Form 4 ↗ |
| 2026-01-29 | 2026-01-27 | Catinazzo Thomas Chief Financial Officer | SSale | −13.8K | $7.62 | $105K | No | Form 4 ↗ |
| 2026-01-29 | 2025-12-31 | Rahmer Peter See remarks | AAward | +994.00 | $2.99 | $2.97K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also RLAY’s full analysis or the market-wide insider trading feed. The tabs above jump to RLAY’s other SEC data.
Source: SEC Form 4 filings for RLAY, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.